Estee Lauder (EL) Executive Receives RSUs and 41,607 Options at $91.77
Rhea-AI Filing Summary
Roberto Canevari, Executive Vice President & CVCO of The Estée Lauder Companies Inc. (EL), reported equity awards dated 08/28/2025. The Form 4 shows three grant types paid in Class A common stock and held directly: 10,821 restricted stock units (annual RSUs) vesting in three equal installments beginning 11/02/2026; 10,727 non-annual RSUs vesting 11/01/2027; and stock options covering 41,607 shares with an exercise price of $91.77, exercisable in three tranches beginning 11/02/2026 and expiring 08/28/2035. The filing was signed by an attorney-in-fact on 09/02/2025.
Positive
- Multi-year vesting aligns executive incentives with long-term shareholder value
- Direct ownership simplifies beneficial ownership and reduces attribution complexity
- Dividend equivalents on RSUs preserve economic value until payout
Negative
- No grant-date dollar values disclosed, limiting assessment of compensation magnitude
- Filing lacks context on percent of outstanding shares or historical grants to assess dilution
Insights
TL;DR: Significant equity grants align executive compensation with share-price performance and retention, structured over multi-year vesting.
The reported awards—annual RSUs, a single non-annual RSU tranche, and multi-year stock options—reflect typical long-term incentive design to retain senior management and tie pay to equity performance. Vesting dates spread across 2026–2028 and option expiry in 2035 create multi-year alignment. All holdings are reported as direct, reducing complexity around indirect beneficial ownership. No additional governance concerns or departures are disclosed in this Form 4.
TL;DR: The aggregate award of 63,155 share-equivalents is material for an executive but lacks disclosed grant-date fair value or company-wide context.
Combining 21,548 RSUs and 41,607 stock options represents a sizable equity grant. The option exercise price is $91.77, and options are exercisable in three roughly equal tranches starting 11/02/2026. RSUs include dividend equivalents paid in cash at payout. The filing provides explicit vesting schedules but does not include award value, percent of outstanding shares, or how grants compare to prior awards, limiting quantitative assessment of dilution or pay magnitude.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units (Share Payout) | 10,821 | $0.00 | -- |
| Grant/Award | Restricted Stock Units (Share Payout) | 10,727 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 41,607 | $0.00 | -- |
Footnotes (1)
- RSUs vest and are paid out in shares of Class A Common Stock on a one-to-one basis on the applicable vesting date. RSUs generally vest in three approximately equal installments unless otherwise indicated. Upon payout, shares are withheld to cover statutory tax obligations. RSUs are accompanied by dividend equivalent rights payable in cash at the time of the payout of the related shares. Not applicable. Annual RSUs granted August 28, 2025. Assuming continued employment, these RSUs will vest and be paid out as follows: 3,607 on November 2, 2026; 3,607 on November 1, 2027; and 3,607 on November 1, 2028. Non-Annual RSUs granted August 28, 2025. Assuming continued employment, these RSUs will vest and be paid out on November 1, 2027. Stock options granted pursuant to The Estee Lauder Companies Inc. Amended and Restated Fiscal 2002 Share Incentive Plan in respect of: 13,869 shares exercisable from and after November 2, 2026; 13,869 shares exercisable from and after November 1, 2027; and 13,869 shares exercisable from and after November 1, 2028.
